Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Anna Sureda
Brentuximab Vedotin Prior to Allogeneic Stem Cell Transplantation in Hodgkin Lymphoma: A Report From the EBMT Lymphoma Working Party
British Journal of Haematology
Hematology
Single Cord Blood Unit Plus Third Party Donor Cells (Haplo-Cord) Transplantation Compared to Adult Unrelated Donors in Patients With Acute Leukemia: A Retrospective Case-Control Study
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Post-Transplant Cyclophosphamide (PTCy)-Based Haploidentical (Haplo) Donor vs. Calcineurin-Inhibitor (CNI)-Based Matched Related Donor (MRD) Reduced-Intensity Conditioning (RIC) Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Classical Hodgkin Lymphoma (cHL)
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
The Aethera Trial: An Ongoing Phase 3 Study of Brentuximab Vedotin in the Treatment of Patients at High Risk of Residual Hodgkin Lymphoma Following Autologous Stem Cell Transplant
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Risk Factors Predicting Outcomes of Autologous Hematopoietic Cell Transplantation (autoHCT) in Children, Adolescents and Young Adults (CAYA) With Relapsed/Refractory (Rel/Ref) Classical Hodgkin Lymphoma (HL): A CIBMTR Analysis
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Fludarabine and Busulfan Versus Fludarabine, Cyclophosphamide, and Rituximab as Reduced-Intensity Conditioning for Allogeneic Transplantation in Follicular Lymphoma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Survival After T-Cell Replete Haploidentical Related Donor Hematopoietic Cell Transplantation (Haplo-Hct) Using Post-Transplant Cyclophosphamide (PT-CY) Compared With HLA-Matched Related Donor (MRD) Transplant for Lymphomas
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
